Exciting news for researchers and professionals in the field of health economics and public policy! The Washington Health Economics Symposium is back this Fall, scheduled from October 5-7, 2025. This event promises to showcase the latest advancements in public policy, financing,

The 1st new class of antibiotics in 30 years? Wright’s team found a lasso peptide that kills bacteria in a novel way. It's promising, but years from the market. scitechdaily.com/the-first-in-3…

“We should already be thinking of ourselves not only as humans but also as part of a more complex symbiosis with the intelligent machines. The … AIs are listening, much like young children might hear their parents arguing outside their bedroom door late at night.” tylercowen

Over 70% of couples choose the exact same Part D plan. Even among couples whose drug needs are very different, the majority still pick the same plan. We create “placebo spouses” based on observables: <20% overlap.

FDA Priority Review Voucher (PRV).

Is AI already impacting the job market? A new paper from me, Erik Brynjolfsson, and Ruyu Chen at Stanford Digital Economy Lab digs into data from ADP. We find some of the ***first large-scale evidence of employment declines for entry-level workers in AI-exposed jobs.*** A thread on our paper:

Today, I am excited to release a paper that has been five years in the making, titled “Endogenous Firm Ownership in General Equilibrium.” I think it is the best thing I have done. nber.org/papers/w34187

An easy improvement in U.S. quality of life would be eliminating all but essential announcements at airports.

📢 Conference announcement! Paolo Surico and I are excited to be organizing this CEPR conference on Public Policies for Innovation. If you work in the #Economics of #Innovation and #InnovationPolicy, please submit + spread the word. Non-presenting attendees also invited.

Updated comparison table of the different FDA Priority Voucher programs.

Total # of job listings on JOE. This year is tracking very similarly to 2020 (worst COVID year). In other words, we're seeing considerably less demand for Econ PhDs than in other post-COVID years; e.g. it's roughly one-third lower than last year.